- Report
- February 2026
- 150 Pages
Global
From €5324EUR$5,950USD£4,553GBP
- Report
- April 2026
- 135 Pages
Global
From €2683EUR$2,999USD£2,295GBP
€3578EUR$3,999USD£3,060GBP
- Report
- August 2026
- 197 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- August 2026
- 284 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- June 2026
- 183 Pages
Global
From €2684EUR$3,000USD£2,295GBP
- Report
- January 2026
- 122 Pages
Global
From €4250EUR$4,750USD£3,635GBP
- Report
- June 2026
- 140 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- January 2026
- 150 Pages
Global
From €5324EUR$5,950USD£4,553GBP
- Report
- January 2026
- 198 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 184 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- January 2026
- 197 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- August 2026
- 476 Pages
Global
From €5234EUR$5,850USD£4,476GBP

The Fetal Bovine Serum (FBS) market is a subset of the biotechnology industry. FBS is a type of serum derived from the blood of unborn calves. It is used in a variety of research and medical applications, such as cell culture, tissue engineering, and drug development. FBS is a valuable resource for scientists and medical professionals, as it contains a variety of growth factors and nutrients that are essential for cell growth and development.
FBS is a highly regulated product, and its production is subject to strict quality control standards. As a result, the FBS market is highly competitive, with a number of companies offering a variety of products. Companies in the FBS market include Sigma-Aldrich, Thermo Fisher Scientific, Merck KGaA, and Bio-Techne. Show Less Read more